TMIST (Tomosynthesis Mammographic Imaging Screening Trial)
TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1096919/syndication
- Syndication ID: 17186
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Tuesday, September 26, 2017 at 02:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM
Embed Code Snippet
To get the embed code snippet please Login.
